Growth Metrics

Nexgel (NXGL) Revenue (2018 - 2025)

Nexgel (NXGL) has disclosed Revenue for 8 consecutive years, with $2.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue changed 0.2% year-over-year to $2.9 million, compared with a TTM value of $11.7 million through Sep 2025, up 73.37%, and an annual FY2024 reading of $8.7 million, up 112.47% over the prior year.
  • Revenue was $2.9 million for Q3 2025 at Nexgel, up from $2.9 million in the prior quarter.
  • Across five years, Revenue topped out at $3.0 million in Q4 2024 and bottomed at $267000.0 in Q1 2021.
  • Average Revenue over 5 years is $1.3 million, with a median of $1.1 million recorded in 2023.
  • The sharpest move saw Revenue surged 426.73% in 2021, then fell 1.5% in 2022.
  • Year by year, Revenue stood at $532000.0 in 2021, then dropped by 1.5% to $524000.0 in 2022, then skyrocketed by 106.49% to $1.1 million in 2023, then surged by 181.05% to $3.0 million in 2024, then dropped by 3.49% to $2.9 million in 2025.
  • Business Quant data shows Revenue for NXGL at $2.9 million in Q3 2025, $2.9 million in Q2 2025, and $2.8 million in Q1 2025.